ストックスクリーナーアプリを入手
0.382
0.58%
0.0022
アフターアワーズ：
.38
-0.002
-0.52%
前日終値:
$0.3798
開ける：
$0.38
24時間の取引高:
172.90K
Relative Volume:
0.24
時価総額：
$56.30M
収益：
-
当期純損益:
$-54.17M
株価収益率:
-1.0327
EPS:
-0.3699
ネットキャッシュフロー:
$-39.34M
1週間 パフォーマンス:
-0.65%
1か月 パフォーマンス:
-8.37%
6か月 パフォーマンス:
-86.01%
1年 パフォーマンス:
-78.05%
1日の値動き範囲:
$0.3791
$0.405
1週間の範囲:
$0.369
$0.405
52週間の値動き範囲:
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.382 | 56.49M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-13 | ダウングレード | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | ダウングレード | Maxim Group | Buy → Hold |
| 2026-03-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | 開始されました | Citizens | Mkt Outperform |
| 2024-05-17 | 開始されました | CapitalOne | Overweight |
| 2023-08-03 | 開始されました | Robert W. Baird | Outperform |
| 2021-08-03 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-07-16 | 再開されました | Maxim Group | Buy |
| 2018-09-28 | 開始されました | B. Riley FBR | Buy |
| 2018-02-15 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Immutep Limited Adr (IMMP) 最新ニュース
Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A - TradingView
Immutep Ltd Sponsored ADR Revenue Breakdown – MUN:YP1A - TradingView
What Triggered Immutep's Securities Class Action Lawsuit - Kavout | AI
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.
Immutep (ASX:IMM) Shares Surge Nearly 14% as Healthcare Momentum Grabs the ASX Spotlight - Kalkine
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
YP1A Forecast — Price Target — Prediction for 2027 - TradingView
Class action lawsuit filed against Immutep afte... - Pluang
Immutep Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsIMMP - Finansavisen
A2H8YL Forecast — Price Target — Prediction for 2027 - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming DeadlinesIMMP - Finansavisen
IMMP Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - PR Newswire
IMMP Investor AlertImmutep Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit - Morningstar
IMM:ASX AnnouncementChange in substantial holding09 Jun 2026 - Market Index
IMMP UPCOMING DEADLINE: Levi & Korsinsky Alerts Immutep Limited Stockholders of Securities Class Action - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי Immutep Ltd. לקבל ייעוץ משפטי לפני מועד אחרון חשוב בתביעה ייצוגית לניירות ערך - GlobeNewswire Inc.
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit - Morningstar
IMMP Shareholder Alert: Immutep Limited Securities Class Action LawsuitInvestors Should Contact SueWallSt - Finansavisen
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline - Finansavisen
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - TMX Newsfile
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel ... - Caledonian Record
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMPImmutep Limited ADR Stock Price and Quote - Finviz
SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026IMMP - Barchart
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class ActionContact The Gross Law Firm - Barchart.com
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Highlights Legal Filing Against Immutep Limited – IMMP - ACCESS Newswire
Immutep Limited Adr (IMMP) 財務データ
収益
当期純利益
現金流量
EPS
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):